Related Experiment Videos
Intravenous immunoglobulin in two children with Guillain-Barré syndrome
L D Notarangelo1, M Duse, S Tiberti
1Department of Paediatrics, University of Brescia, Italy.
European Journal of Pediatrics
|April 1, 1993
Two children with Guillain-Barrè syndrome were successfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome.
Two children with Guillain-Barrè syndrome were successfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome.